Cargando…
Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma
PURPOSE: Abnormal CLEC9A expression is concerned with carcinogenesis. However, the role of CLEC9A in lung adenocarcinoma (LUAD) remains unknown. The goal of this study was to reveal the role of CLEC9A in LUAD based on bioinformatics and cellular functional experiments. MATERIALS AND METHODS: Data av...
Autores principales: | Miao, Fang, Lou, Zhiguo, Ji, Shuhua, Wang, Dan, Sun, Yaolan, Liu, Huan, Yang, Chenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489846/ https://www.ncbi.nlm.nih.gov/pubmed/34616670 http://dx.doi.org/10.3389/fonc.2021.682814 |
Ejemplares similares
-
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021) -
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
por: Liu, Jun, et al.
Publicado: (2023) -
m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma
por: Liu, Yafei, et al.
Publicado: (2023) -
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis
por: He, Yi, et al.
Publicado: (2021) -
Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Xu, Ting, et al.
Publicado: (2022)